NEWS

NEWSNEWS

24
Feb

The facility will house two high-end electron microscopes which determine protein structures and materials at the atomic level

INSTITUCIONAL
16
Feb

CRG researcher is one of fourteen individuals recognised by the city’s government

DISTINCIONS I PREMIS
13
Feb

Atlas of circadian and circannual variation reveals therapeutic targets which could benefit from different doses depending on time of day and season

RECERCA
09
Feb
The image shows pancreatic islets in mice, specialised tissues that host beta cells. On the left, a healthy pancreatic islet is shown with its typical morphology with alpha cells in the periphery and beta cells in the core of the islet. On the right, mice with a mutation in Srrm3 that knock out the cells’ ability to regulate microexon inclusion results in islets with altered morphology and cell identity. This and other functional alterations ultimately impacts on the release of insulin. Jonas Juan Mateu

Microexons constitute new potential therapeutic targets for treating diabetes

RECERCA
31
Jan

Elvan Böke’s research group receives a 2-million-euro European Research Consolidator grant

FINANçAMENT
19
Jan
This shows a cross-section of a mouse lung infected with Pseudonomas aeruginosa. The mouse was treated with a version of Mycoplasma pneumoniae that could not produce therapeutic molecules, resulting in severe pneumoniae. This is characterised by massive infiltration of inflammatory cells into the alveolar septa, resulting in loss of air in the alveoli. Credit: Rocco Mazzolini/CRG

Study showcases synthetic biology's potential in transforming treatment of human disease

RECERCA
28
Dec

RNA splicing regulation influences transcription of genes inked to type-1 and type-1 diabetes risk

RECERCA
14
Dec

European Innovation Council backs CRG start-up to further efforts in treating leading cause of cancer mortality worldwide

28
Nov
Image 1. Mitotic spindles with microtubules (red) attached to chromosomes (blue) during cell division. Cells with normal TTLL11 function (right) have normal rates of microtubule polyglutamylation (green) while cells without TTLL11 (left) are unmodified. Isabelle Vernos

The enzyme’s activity was found to be compromised in human cancer cells

RECERCA
24
Nov

Luciano Di Croce and Isabelle Vernos will identify and validate new therapeutics targets for breast cancer and midline gliomas

FINANçAMENT

Pages